NCT07007351View on ClinicalTrials.gov

Multicenter, Prospective Study to Determine the Performance and Safety of the New M-HA30 Architect Device on the Quality of the Skin: HEBE8 Study

NACompletedINTERVENTIONAL

Enrollment

285

Participants

Timeline

Start Date

March 19, 2023

Primary Completion Date

April 13, 2024

Study Completion Date

June 13, 2024

Conditions

Skin Aging

Interventions

DEVICE

Intradermal injection

The product is the first solution with free hyaluronic acid boosted with silicium the administration mode is same as any other intradermal multi-injection procedure

Trial Locations (1)

75008

Fillmed Laboratoires, Paris